جستجوی استاد راهنمای دانشگاهی

• Neurovascular Surgery
• Cerebrovascular Disorders
• Stroke Intervention
• +۳ مورد دیگر

Ryan M Hebert, MD, is an Assistant Professor of Neurosurgery at the Yale School of Medicine, affiliated with the Neurosurgery department. He specializes in neurovascular disorders, including open and endovascular treatments for intracranial aneurysms, arteriovenous malformations, carotid disease, and dural arteriovenous fistulas. He also focuses on interventions for ischemic and hemorrhagic strokes. His practice locations include Yale New Haven Hospital and Lawrence and Memorial Hospitals in Connecticut. Education & Training: Bachelor’s in Molecular, Cellular, and Developmental Biology from the University of Colorado – Boulder (Howard Hughes Undergraduate Research Grant recipient) MD from Yale School of Medicine (NIH-funded thesis on CCM3 in cerebral cavernous malformations) 7-year Neurosurgery Residency at Yale New Haven Hospital, including enfolded neuro-interventional training CAST-accredited fellowship in Endovascular Neurosurgery and Neurovascular Critical Care at Thomas Jefferson University Hospital (2016) Research Interests: Dr. Hebert’s work centers on emerging surgical and endovascular techniques for neurovascular disorders, risk stratification in carotid disease, vasospasm prediction/post-subarachnoid hemorrhage treatment, and outcomes of minimally invasive spine surgery. His studies often integrate clinical practice with translational research, emphasizing patient outcomes and procedural optimization. Key topics include flow diverters, cranial nerve palsies, hospital frailty risk scores, and immune mechanisms driving aneurysm rupture. Publications Trends: His recent articles emphasize clinical outcomes of endovascular procedures, stroke interventions, and immune mechanisms in aneurysm rupture. He frequently collaborates on meta-analyses and systematic reviews to evaluate treatment efficacy and complication rates, particularly involving cranial nerve recovery and thrombectomy volumes. Awards & Grants: He secured an NIH-funded thesis and a Howard Hughes Undergraduate research grant. No explicit scientific awards are listed, but his work has been recognized via peer-reviewed publications and contributions to clinical guidelines. Advising & Grants: While no students are listed, he collaborates with prominent researchers like Charles Matouk, Kevin Sheth, and Joseph Antonios on NIH-funded projects. His research addresses healthcare resource utilization and procedural volume impacts on mortality, indicating a focus on translational and clinical studies. Labs & Teams: Active in interdisciplinary teams at Yale School of Medicine, particularly in neurovascular critical care and endovascular surgery. Collaborates with the Stroke Center and Janeway Society for physician-scientist development.

• Cardiovascular Disease
• Coronary Microvascular Dysfunction
• Invasive Coronary Function Testing
• +۳ مورد دیگر

Nida Latif is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine. Her work focuses on understanding coronary microvascular dysfunction and ischemic heart disease in patients with nonobstructive coronary arteries, particularly in women. She is a key contributor to the DISCOVER INOCA multicenter registry, evaluating invasive coronary function testing protocols and diagnostic strategies. Her research integrates clinical, anatomical, and physiological data to improve diagnostic accuracy and patient outcomes. Key areas of investigation include coronary vasoreactivity testing, risk factor analysis in ischemic syndromes, and the impact of diabetes on angina pathophysiology. Latif's publications highlight advancements in coronary flow reserve measurement, comparison of diagnostic modalities (e.g., PET vs thermodilution), and the clinical utility of vessel-specific analysis. Her work emphasizes translational outcomes, bridging basic science insights with clinical practice improvements. While no specific awards are listed, her contributions to high-impact clinical registries and peer-reviewed publications reflect her active role in advancing cardiovascular medicine.

Nivee Pradip Aminمشاهده پروفایل

استادیار بالینی

• Cardiovascular Disease
• Women's Cardiovascular Health
• Preventive Cardiology
• +۳ مورد دیگر

Dr. Nivee Pradip Amin serves as Clinical Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at NewYork-Presbyterian Hospital, holding leadership roles as Associate Director for Consultative Cardiology and Director of the Women's Heart Program & Preventive Cardiology. Her clinical expertise spans general cardiology, preventive cardiology, and echocardiography with focus on high-risk cardiovascular prevention. Her educational credentials include: B.A., B.S. in International Studies and Business from University of Pennsylvania (2002) M.D. from Johns Hopkins University School of Medicine (2007) M.H.S. in Clinical Investigation from Johns Hopkins Bloomberg School of Public Health (2013) Research centers on sex-based disparities in cardiovascular outcomes, women's heart health across the lifespan, and preventive strategies for coronary/valvular disease. She investigates intersections between cardiology and obstetrics/oncology, emphasizing personalized risk assessment and early intervention to improve quality of life. Analysis of her publications reveals consistent focus on women's cardiovascular biomarkers (e.g., breast arterial calcium), obstetric complications as long-term risk factors, and disparities in revascularization outcomes. Her work leverages large-scale database analysis to address gaps in preventive care for high-risk populations including cancer patients and those with cirrhosis. Dr. Amin maintains active board certifications in Internal Medicine, Cardiovascular Diseases, Nuclear Cardiology, and Echocardiography through the American Board of Internal Medicine, and holds professional memberships in the American College of Cardiology, American Society for Preventive Cardiology, and American Heart Association. She provides inpatient consultative care on cardiac telemetry units while leading the Women's Heart Program, which integrates preventive cardiology services with gender-specific treatment protocols. Fluent in Spanish, she emphasizes culturally competent care tailored to individual patient needs across diverse populations.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

• Health Technology
• Clinical Epidemiology
• Digital Healthcare
• +۵ مورد دیگر

Carine J.M. Doggen is a Full Professor in Health Technology & Services Research at the TechMed Centre, University of Twente. She also serves as Scientific Director at Rijnstate Hospital since October 2017. Her academic career includes previous positions as Senior Researcher at Leiden University Medical Center (2000-2009), University of Washington, Seattle (2002-2003), and Sanquin Blood Bank (2006-2009). Her research focuses on evaluating healthcare innovations, particularly technologies enabling the transition of care from hospitals to home settings. Dr. Doggen specializes in assessing the implementation, reliability, and effectiveness of new medical technologies including wearable sensors and remote monitoring systems. Her work examines measurement validity and incorporates perspectives from both healthcare providers and patients. Analysis of her recent publications reveals strong expertise in cardiovascular technology evaluation, digital health interventions, and quality of life assessment. Her research shows particular strength in randomized clinical trials of medical devices, health technology assessment methodologies, and post-COVID health outcomes research. Dr. Doggen has presented her work at numerous conferences, with recent oral presentations including 'Towards personalised medicine: the potential of intensive longitudinal data to assess the interplay of chronic diseases' (2024) and 'Prognostic markers for acute heart failure in Chronic Obstructive Pulmonary Disease' (2021). She has also contributed to media discussions about healthcare innovations through the Rijnstate Collegetour series.

Tanya N Turanمشاهده پروفایل

استاد

• Management of Vascular Risk Factors in Stroke
• Intracranial Atherosclerosis
• Secondary Stroke Prevention
• +۳ مورد دیگر

Dr. Tanya N Turan is a tenured Professor of Neurology at the Medical University of South Carolina (MUSC), serving as Vice-Chair of Neurology Faculty Affairs. She is a director of the NIH-StrokeNet Regional Coordinating Center "Southeast Collaborative Alliance for Stroke Trials (SE-CoAST)" and actively oversees multi-center clinical trials including SAMMPRIS, CREST 2, and CAPTIVA. Research Interests: Management of vascular risk factors in stroke Intracranial atherosclerosis Secondary stroke prevention Medical imaging techniques for plaque analysis Hypertensive disorders in pregnancy Hemodynamic assessment in cerebrovascular disease Clinical Trials & Grants: NIH-funded SAMMPRIS (Stenting vs. Aggressive Medical Management) CREST 2 (Carotid Revascularization Endarterectomy/Stenting) CAPTIVA (Anticoagulation vs. Antiplatelet Therapies) National StrokeNet infrastructure leadership Publication Trends: Her recent work focuses on intracranial atherosclerosis, vascular risk factors, and hemodynamic effects in stroke. Articles emphasize clinical trials, imaging biomarkers, and long-term outcomes in cerebrovascular disease.

• Cerebrovascular Surgery
• Endovascular Neurosurgery
• Skull Base Surgery
• +۶ مورد دیگر

Karol Budohoski, MD, PhD, FRCS, is an Assistant Professor in the Department of Neurosurgery at the University of Utah , with additional Adjunct Assistant Professor status in Radiology & Imaging Sciences. He specializes in cerebrovascular , endovascular , and skull base neurosurgery , treating complex pathologies like brain aneurysms, arteriovenous malformations, and skull base tumors. Education: PhD in Neurosurgery (University of Cambridge), MD (Medical University of Warsaw), Clinical Fellowships at University of Utah and UCSF His academic focus on subarachnoid hemorrhage pathophysiology and cerebral vasospasm has led to innovations in brain monitoring tools. Recent publications (2023-2025) span neurovascular surgery , stroke interventions , global neurosurgery , and cerebral autoregulation studies. He practices at the Clinical Neurosciences Center in Salt Lake City, Utah, with a patient rating of 4.9/5 (125 reviews), praised for clarity, attentiveness, and technical expertise.

Michael S. Conteمشاهده پروفایل

استاد

• Vascular Surgery
• Peripheral Artery Disease
• Aortic Disease
• +۷ مورد دیگر

Dr. Michael S. Conte is Professor of Surgery at the University of California, San Francisco (UCSF) School of Medicine, where he serves as Co-director of the UCSF Heart & Vascular Center and Chief of the Division of Vascular & Endovascular Surgery. Specializing in vascular surgery, Dr. Conte focuses on diseases of the aorta, aneurysms, carotid artery disease, peripheral artery disease (PAD), and diabetic vascular disease, performing complex revascularization procedures to preserve limb function and prevent amputations. Dr. Conte received his medical degree from Albert Einstein College of Medicine in 1986, completed surgical residency at Weill Cornell Medicine, and vascular surgery training at Brigham and Women's Hospital and Harvard Medical School. His clinical and research work has significantly advanced the field of vascular surgery, particularly in chronic limb-threatening ischemia (CLTI) management. Dr. Conte's research interests center on vascular interventions, limb preservation strategies, diabetic foot complications, and vascular disease outcomes. He led the largest multicenter clinical trial of leg bypass surgery for severe PAD and has been instrumental in the BEST-CLI trial comparing surgical versus endovascular approaches for CLTI. His work investigates mechanisms of vascular injury response, angioplasty and bypass failure, and methods to identify patients at risk for poor outcomes. Analysis of Dr. Conte's recent publications (2023-2025) reveals a strong emphasis on CLTI management, diabetic foot care, health disparities in vascular treatment, and quality improvement in vascular surgery. His research spans clinical trials, systematic reviews, guideline development, and health services research, demonstrating consistent contributions to evidence-based vascular care. American Heart Association 2019 Peripheral Vascular Disease Distinguished Achievement Award San Francisco Magazine 2016 Bay Area Top Doctors Best Doctors, Inc. 2015 Best Doctors in America New York Weill Cornell Medical Center Alumni Council 2006 Distinguished Achievement Award NHLBI/Lifeline 1999 Mentored Clinical Scientist Development Award Dr. Conte has secured significant NIH funding for research on diabetic foot care and vascular interventions, serving as Principal Investigator on multiple grants including the UCSF Diabetic Foot Clinical Research Unit (NIH U01DK119100) and research on specialized lipid mediators in vascular injury (NIH R01HL119508). He has established multidisciplinary 'toe and flow' programs at UCSF focused on limb preservation for patients with diabetic foot complications. As an active member of the Society for Vascular Surgery and Society of University Surgeons, Dr. Conte serves on editorial boards for leading vascular journals and has contributed to clinical practice guidelines. His clinical practice emphasizes complex revascularization procedures, and he is board certified in Vascular Surgery by the American Board of Surgery.

Abdul Ihdayhidمشاهده پروفایل

دانشیار

• Cardiovascular Medicine
• Cardiac Imaging
• Artificial Intelligence in Cardiology
• +۳ مورد دیگر

Associate Professor Abdul Ihdayhid is a Research Leader in Cardiovascular Biology at the Curtin Medical School , Curtin University, within the Faculty of Health Sciences. His work focuses on advanced cardiac imaging techniques, particularly coronary CT angiography, fractional flow reserve modeling, and AI integration in cardiovascular diagnostics. Key Research Areas: Cardiovascular imaging, artificial intelligence applications, aortic stenosis interventions, and ethical implications of AI in medicine. Recent Publications: Analysis of high-risk coronary plaque, telehealth adaptations during pandemics, and AI-driven CAC scoring innovations. Collaborations: Extensive partnerships with institutions across Australia and New Zealand on multicenter studies like the Australian-New Zealand SCAD cohort. His 2024-2025 work emphasizes machine learning for plaque quantification and ethical frameworks in AI implementation. Email: Abdul.Ihdayhid@curtin.edu.au

• Stroke
• Vascular Neurology
• Intracranial Atherosclerosis
• +۵ مورد دیگر

Adam de Havenon, MD, MSCI is an Associate Professor of Neurology at Yale School of Medicine specializing in vascular neurology. He leads the de Havenon Lab which focuses on reducing stroke risk, preventing recurrent strokes, and improving post-stroke recovery outcomes. His clinical practice includes evaluating and treating acute strokes in hospital and emergency settings, as well as providing outpatient stroke consultations. Dr. de Havenon earned his BA in American Studies from Yale University in 2001, followed by his MD from Brown Medical School in 2009. He completed neurology residency at the University of Utah in 2013 and a vascular neurology fellowship at University of Washington in 2014. In 2021, he completed a Masters of Science in Clinical Investigation degree. After serving as faculty at the University of Utah from 2014-2021, he returned to Yale in late 2021. His research spans intracranial atherosclerosis, blood pressure variability, vascular cognitive impairment, white matter hyperintensity, and advanced neuroimaging techniques. Dr. de Havenon has published over 150 peer-reviewed articles and his work focuses on bridging basic science of stroke research with human implementation. His publications from 2024-2025 demonstrate strong emphasis on stroke risk prediction, vascular risk factor management, neuroimaging techniques, and health disparities in stroke outcomes. Dr. de Havenon has secured competitive grant funding including K23, R01, and UG3/UH3 awards from NIH/NINDS. He serves as principal investigator for the BP-VISO study and StrokeNet study CAPTIVA-MRI. His mentees have received prestigious awards including NIH NRS training grants and American Academy of Neurology Medical Student Research Scholarships. He established the de Havenon Lab first at his prior institution and then at Yale in 2022, where it continues to expand its footprint in cerebrovascular research and training the next generation of researchers. The lab's mission is to advance research that benefits stroke patients while addressing gaps and disparities in stroke prevention and care.

Christopher J. Cooperمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Interventional Cardiology
• Renovascular Hypertension
• +۴ مورد دیگر

Christopher J. Cooper, M.D., is Distinguished University Professor of Medicine at the University of Toledo, Ohio, where he also served as Dean of the College of Medicine (2014-2024), CEO of University of Toledo Physicians, and Executive Vice-President for Clinical Affairs. Triple-board-certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology, he directs the UT Clinical Coordinating Center and has led national randomized trials on renal-artery stenosis. Education & Training: B.A. magna cum laude in Biology (Philosophy minor), Wittenberg University, 1985 M.D., University of Cincinnati College of Medicine, 1988 — Valedictorian, Alpha Omega Alpha Internship & Residency, Brigham and Women’s Hospital / Harvard Medical School, 1988-1991 Cardiology Fellowship, Brigham and Women’s Hospital, 1991-1994 Harvard School of Public Health, Clinical Effectiveness Program, 1992 Research Focus: Cooper’s group investigates renovascular hypertension, renal-artery stenosis, and cell-based therapies for vascular disease. As PI of the NIH-funded CORAL trial and multiple industry grants, he has published pivotal papers defining when renal stenting benefits patients and elucidating inflammatory and signaling pathways that couple renal artery narrowing to hypertension and renal failure. Recent work integrates large-scale clinical outcomes databases with mechanistic studies on Na/K-ATPase signaling, microRNA regulation of cardiac fibrosis, and biomarkers such as CD40-ligand in renovascular disease. Honors & Awards: Best Doctors in America — multiple years (2002-2014) America’s Top Doctors, Castle Connolly — consecutive listings (2006-2015) College of Medicine Award for Excellence in Clinical Research, UT (2008) Elected Fellow, American Heart Association Council on High Blood Pressure Research (2004) Valedictorian & Alpha Omega Alpha, Univ. of Cincinnati (1988) Leadership & Grants: Cooper has held continuous NIH and industry funding for multicenter trials; he founded and directs the UT Clinical Coordinating Center, overseeing regulatory, data, and biostatistical cores for national studies. His administrative leadership spans Department Chair, Heart & Vascular Center Director, and Dean of the College of Medicine, while maintaining an active interventional cardiology practice. Laboratory & Teams: He leads the Cooper Renal & Vascular Research Group within the UT Cardiovascular Research Institute, mentoring faculty, fellows, and graduate students in translational protocols that bridge molecular cardiology, interventional imaging, and large pragmatic trials.

Edward S. Ahnمشاهده پروفایل

استاد

• Pediatric Neurosurgery
• Neurovascular Surgery
• Fetal Surgery
• +۳ مورد دیگر

Edward S. Ahn, M.D., is a Professor of Neurosurgery and Pediatrics at Mayo Clinic in Rochester, Minnesota. As a pediatric neurosurgeon, he specializes in minimally invasive techniques for craniosynostosis, fetal surgery for myelomeningocele, and management of pediatric neurovascular disorders like arteriovenous malformations and moyamoya disease. Education: B.A. in Biology and East Asian Studies, Harvard University (1999) M.D., New York University School of Medicine (2000) Internship in General Surgery, University of Maryland Medical Center (2001) Residency in Neurosurgery, University of Maryland Medical Center (2006) Fellowship in Pediatric Neurosurgery, Children’s Hospital (2007) Dr. Ahn’s research focuses on improving surgical outcomes for children with neurosurgical conditions, including craniosynostosis , hydrocephalus , and Chiari malformation . He pioneered image-based craniometric diagnostics for early craniosynostosis detection and explores telehealth applications for neonatal cranial screening. His recent work analyzes machine learning integration in surgical diagnostics. His publications span pediatric neurosurgical outcomes , fetal interventions , and vascular anomaly management . Dr. Ahn serves on editorial boards for Journal of Neurosurgery: Pediatrics and Child's Nervous System , and has received multiple Top Doctor recognitions since 2011. He also contributes to surgical education as Director of Neurosurgical Medical Student Education at Johns Hopkins University (2013–2014).

• General Surgery
• Trauma Surgery
• Acute Care Surgery
• +۷ مورد دیگر

Phillip Dowzicky is an Assistant Professor in the Department of Surgery-Trauma and Acute Care at the University of Chicago's Pritzker School of Medicine. His academic work bridges clinical surgery with health services research, focusing on trauma systems, acute care surgery, and the socioeconomic dimensions of surgical care. Dr. Dowzicky's research spans several critical areas in modern surgical practice: Financial toxicity and economic impacts on surgical patients Trauma systems and crime victim compensation mechanisms Health equity and disparities in surgical outcomes Quality improvement in emergency and acute care surgery Post-discharge care transitions and patient experiences His publication record shows significant scholarly activity with a concentration of impactful work since 2019. Dr. Dowzicky has published in premier surgical journals including Annals of Surgery, JAMA Surgery, and the Journal of Trauma and Acute Care Surgery. His systematic review on race, gender, and language concordance in surgical care (2019) has garnered substantial attention with 14 citations, indicating its influence in the field. Dr. Dowzicky's work on crime victim compensation represents a distinctive intersection of trauma surgery and social policy, with recent 2025 publications examining Illinois' system for sexual assault and domestic violence victims. His contributions to the four-part series on value in acute care surgery demonstrate his expertise in healthcare economics as it relates to surgical services. He maintains active collaborations with colleagues at the University of Chicago including Justin Hatchimonji, Charlotte Kvasnovsky, Carmelle Romain, Tanya Zakrison, and Diane Haddad. His research often involves multi-institutional partnerships through organizations like the AAST Health Economics Committee, reflecting the collaborative nature of modern surgical research.

Mirza Umair Khalidمشاهده پروفایل

استادیار

• Intracoronary Imaging
• 3D and Structural Echocardiography
• Invasive Cardiac Hemodynamics
• +۳ مورد دیگر

Mirza Umair Khalid, M.D., is an Assistant Professor in the Department of Medicine-Cardiology at Baylor College of Medicine and Director of the Cardiac Care Unit at the Michael E. DeBakey VA Medical Center in Houston. He holds dual roles as Associate Program Director (Academics) for the Cardiology Fellowship Program and Clinical Educator. His academic portfolio includes over 70 peer-reviewed publications and active leadership in national committees like the American College of Cardiology's PINNACLE R&P Committee. Dr. Khalid completed his MBBS at Aga Khan Medical School (2009), followed by Internal Medicine residency and Cardiology fellowship at Baylor College of Medicine (2013–2018). Research focuses on intracoronary imaging, structural echocardiography, and complex coronary interventions. He leads quality improvement initiatives in the VA CCU and oversees BCM Cardiology Fellowship’s academic training, including lecture series, board review, and M&M conferences. Awards include the BCM Early Career Award (2021) and recognition as Best Teaching Faculty (2020). Professional memberships span the American College of Cardiology, American Heart Association, and National Cardiovascular Data Registry (NCDR) committees. His clinical expertise spans six certifications, including Interventional Cardiology, Echocardiography, and Cardiac CT.

Tze-Woei Tanمشاهده پروفایل

دانشیار بالینی

• Vascular Surgery
• Peripheral Artery Disease
• Diabetes
• +۴ مورد دیگر

Dr. Tze-Woei Tan is a Clinical Associate Professor in the Department of Surgery at the Keck School of Medicine, University of Southern California, where he directs the Limb Salvage Research Program. He holds an MD from the University of Melbourne, completed residency at Brown University, vascular surgery fellowship at Boston University, and an MPH from the University of Arizona. His NIH-supported research focuses on reducing amputations in peripheral artery disease and diabetes through innovative interventions. Research explores health disparities, minimally invasive surgical techniques, and diabetic vascular complications. Recent work investigates telemedicine applications in acute care, frailty assessment in surgical outcomes, and racial disparities in amputation recovery. Articles consistently address integrated care models for complex vascular conditions and diabetic foot ulcer prevention. Honors include the Roger E. Pecoraro Award from the American Diabetes Association (2023) and the Keck Faculty Teaching Award (2024). Leads NIH-funded projects on limb preservation and mentors trainees in clinical research methodologies. Directs the Limb Salvage Research Lab, collaborating with podiatry, endocrinology, and health policy experts to develop multidisciplinary care pathways for high-risk populations.